ÂÜÀòÂÒÂ×

Meg is Director of Investments at Sanofi Ventures, the corporate venture capital arm of Sanofi. Prior to joining Sanofi Ventures, Meg was Director of Business Development, External Innovation at Vertex Pharmaceuticals. Previous to Vertex, Meg was a Senior Associate at RA Capital, where she supported public and private investments across a variety of areas including genetic medicines, rare disease, and neuroscience. Meg holds a Ph.D. in Neuroscience from Massachusetts Institute of Technology and B.S. with Distinction and Honors in Neuroscience from The Pennsylvania State University.